Tweet
Irish Times
<img alt="" height="1" width="1" />
Novo says US setback won't affect Tresiba plans in Europe, Japan
Reuters
COPENHAGEN | Mon Feb 11, 2013 2:54am EST. COPENHAGEN Feb 10 (Reuters) - Denmark's Novo Nordisk said a request from U.S. authorities to conduct additional clinical tests on its new long-acting insulin Tresiba would have no impact on its plans for ...
Novo Nordisk sinks 14% on disappointing drug newsMarketWatch
Novo Nordisk Insulin Fails to Win FDA's BackingBloomberg
Seeking Cardiovascular Safety Data, FDA Blocks Approval Of Novo Nordisk's ...Forbes
New York Times -Financial Times -Reuters UK
all 15 news articles »
More...